Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,417.15INR
22 May 2018
Change (% chg)

Rs40.55 (+1.71%)
Prev Close
Rs2,376.60
Open
Rs2,377.00
Day's High
Rs2,447.50
Day's Low
Rs2,352.10
Volume
7,412
Avg. Vol
11,232
52-wk High
Rs2,700.00
52-wk Low
Rs2,020.00

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 8,215.00 8,215.00 8,215.00 --
Year Ending Mar-18 10 30,655.10 32,896.20 29,140.00 32,691.80
Year Ending Mar-19 10 34,406.00 37,704.90 32,596.00 36,952.70
Earnings (per share)
Year Ending Mar-18 10 41.86 49.10 37.49 49.49
Year Ending Mar-19 10 50.56 57.70 40.29 55.72
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 61.46 28.56 32.59
P/E High - Last 5 Yrs. -- 41.38 47.07
P/E Low - Last 5 Yrs. -- 23.34 24.59
Beta 0.35 0.80 0.79
Price to Sales (TTM) 13.91 4.18 9.01
Price to Book (MRQ) -- 3.50 4.24
Price to Tangible Book (MRQ) -- 4.37 5.79
Price to Cash Flow (TTM) 173.13 19.51 21.78
% Owned Institutions -- 1.29 2.43

Dividends

  Company industry sector
Dividend Yield 1.26 1.79 1.66
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.15
Payout Ratio(TTM) 0.00 16.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.99 5.10
Sales (TTM) vs TTM 1 Yr. Ago -- 10.28 12.65
Sales - 5 Yr. Growth Rate -- 7.42 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 37.70 33.25
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 7.07 8.54
Capital Spending - 5 Yr. Growth Rate -- 8.26 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.50
Current Ratio (MRQ) -- 3.58 3.56
LT Debt to Equity (MRQ) -- 10.41 12.86
Total Debt to Equity (MRQ) -- 12.80 15.83
Interest Coverage (TTM) -- 40.27 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 55.48 54.64
Gross Margin - 5 Yr. Avg. -- 52.71 52.74
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.50 15.84
Operating Margin (TTM) 33.89 12.71 -2.34
Operating Margin - 5 Yr. Avg. -- 14.23 11.09
Pre-Tax Margin (TTM) 33.89 13.00 -0.23
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 11.29
Net Profit Margin (TTM) 23.12 9.41 -3.64
Net Profit Margin - 5 Yr. Avg. -- 10.79 7.58
Effective Tax Rate (TTM) 31.77 22.43 31.25
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 831,280,368 721,262,098
Net Income/Employee (TTM) 718,922 96,677,550 83,813,821
Receivable Turnover (TTM) -- 5.53 5.67
Inventory Turnover (TTM) -- 2.50 3.55
Asset Turnover (TTM) -- 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.44 9.98
Return on Assets - 5 Yr. Avg. -- 11.65 11.07
Return on Investment (TTM) -- 13.05 12.60
Return on Investment - 5 Yr. Avg. -- 15.07 14.34
Return on Equity (TTM) -- 14.79 14.49
Return on Equity - 5 Yr. Avg. -- 16.32 15.71
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.73 -2.20 99 10
13 Week -2.34 -4.71 99 11
26 Week -4.67 -8.12 99 12
52 Week -2.92 -14.56 99 11
YTD -4.53 -6.07 99 12
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.44%
# of Holders: 18
Total Shares Held: 9,692,216
3 Mo. Net Change: 95,314
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 3
# Reduced Positions: 8
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.